Access the full text.
Sign up today, get DeepDyve free for 14 days.
L. Sullivan, D. Wallace, J. Grantham (1998)
Epithelial transport in polycystic kidney disease.Physiological reviews, 78 4
Luis Galietta, Mark Springsteel, M. Eda, E. Niedzinski, Kolbot By, M. Haddadin, M. Kurth, M. Nantz, A. Verkman (2001)
Novel CFTR Chloride Channel Activators Identified by Screening of Combinatorial Libraries Based on Flavone and Benzoquinolizinium Lead Compounds* 210The Journal of Biological Chemistry, 276
O. Zegarra‐Moran, M. Monteverde, Luis Galietta, O. Moran (2007)
Functional Analysis of Mutations in the Putative Binding Site for Cystic Fibrosis Transmembrane Conductance Regulator PotentiatorsJournal of Biological Chemistry, 282
K. Lansdell, S. Delaney, D. Lunn, S. Thomson, Dean Sheppard, Brandon Wainwright (1998)
Comparison of the gating behaviour of human and murine cystic fibrosis transmembrane conductance regulator Cl− channels expressed in mammalian cellsThe Journal of Physiology, 508
O Zegarra-Moran, M Monteverde, LJV Galietta, O Moran (2007)
Functional analysis of mutations in the putative binding site for cystic fibrosis transmembrane conductance regulatot potentiators. Interaction between activation and inhibitionJ Biol Chem, 282
M. Welsh, Alan Smith (1993)
Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosisCell, 73
P. Vergani, S. Lockless, A. Nairn, D. Gadsby (2005)
CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domainsNature, 433
B. Illek, Mike Lizarzaburu, Vivien Lee, M. Nantz, Mark Kurth, Horst Fischer (2000)
Structural determinants for activation and block of CFTR-mediated chloride currents by apigenin.American journal of physiology. Cell physiology, 279 6
O. Hamill, A. Marty, E. Neher, B. Sakmann, F. Sigworth (1981)
Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patchesPflügers Archiv, 391
E. Caci, C. Folli, O. Zegarra‐Moran, T. Ma, Mark Springsteel, R. Sammelson, M. Nantz, M. Kurth, A. Verkman, L. Galietta (2003)
CFTR activation in human bronchial epithelial cells by novel benzoflavone and benzimidazolone compounds.American journal of physiology. Lung cellular and molecular physiology, 285 1
Oscar Moran, Luis Galietta, O. Zegarra‐Moran (2005)
Binding site of activators of the cystic fibrosis transmembrane conductance regulator in the nucleotide binding domainsCellular and Molecular Life Sciences CMLS, 62
Tomohiko Ai, S. Bompadre, Xiaohui Wang, Shenghui Hu, Min Li, T. Hwang (2004)
Capsaicin potentiates wild-type and mutant cystic fibrosis transmembrane conductance regulator chloride-channel currents.Molecular pharmacology, 65 6
O. Moran, O. Zegarra‐Moran (2005)
A quantitative description of the activation and inhibition of CFTR by potentiators: GenisteinFEBS Letters, 579
K. Lansdell, Z. Cai, J. Kidd, D. Sheppard (2000)
Two mechanisms of genistein inhibition of cystic fibrosis transmembrane conductance regulator Cl− channels expressed in murine cell lineThe Journal of Physiology, 524
P. Vergani, A. Nairn, D. Gadsby (2003)
On the Mechanism of MgATP-dependent Gating of CFTR Cl− ChannelsThe Journal of General Physiology, 121
F. Weinreich, P. Wood, J. Riordan, G. Nagel (1997)
Direct action of genistein on CFTRPflügers Archiv, 434
F Wang, S Zeltwanger, I Yang, A Nairn, T Hwang (1998)
Actions of genistein on cystic fibrosis transmembrane conductance regulator channel gating. Evidence for two binding sites with opposite effectsJ Gen Physiol, 111
C. Randak, E. Auerswald, I. Assfalg‐Machleidt, W. Reenstra, W. Machleidt (1999)
Inhibition of ATPase, GTPase and adenylate kinase activities of the second nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator by genistein.The Biochemical journal, 340 ( Pt 1)
F. Becq, Y. Mettey, M. Gray, Luis Galietta, R. Dormer, M. Merten, T. Métayé, V. Chappe, Cécie Marvingt-Mounir, O. Zegarra‐Moran, R. Tarran, Laurence Bulteau, R. Dérand, M. Pereira, M. McPherson, C. Rogier, M. Joffre, B. Argent, D. Sarrouilhe, W. Kammouni, C. Figarella, B. Verrier, M. Gola, J. Vierfond (1999)
Development of Substituted Benzo[c]quinolizinium Compounds as Novel Activators of the Cystic Fibrosis Chloride Channel*The Journal of Biological Chemistry, 274
L. Smit, D. Wilkinson, M. Mansoura, F. Collins, D. Dawson (1993)
Functional roles of the nucleotide-binding folds in the activation of the cystic fibrosis transmembrane conductance regulator.Proceedings of the National Academy of Sciences of the United States of America, 90 21
C. Haws, I. Nepomuceno, M. Krouse, Heather Wakelee, T. Law, Yong Xia, H. Nguyen, J. Wine (1996)
Delta F508-CFTR channels: kinetics, activation by forskolin, and potentiation by xanthines.The American journal of physiology, 270 5 Pt 1
A. Taddei, C. Folli, O. Zegarra‐Moran, P. Fanen, A. Verkman, Luis Galietta (2004)
Altered channel gating mechanism for CFTR inhibition by a high‐affinity thiazolidinone blockerFEBS Letters, 558
J. Riordan (1989)
Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNATrends in Genetics, 5
H. Vais, Rugang Zhang, W. Reenstra (2004)
Dibasic phosphorylation sites in the R domain of CFTR have stimulatory and inhibitory effects on channel activation.American journal of physiology. Cell physiology, 287 3
B. Schultz, A. Singh, D. Devor, R. Bridges (1999)
Pharmacology of CFTR chloride channel activity.Physiological reviews, 79 1 Suppl
O. Zegarra‐Moran, L. Romio, C. Folli, E. Caci, F. Becq, J. Vierfond, Y. Mettey, G. Cabrini, P. Fanen, Luis Galietta (2002)
Correction of G551D‐CFTR transport defect in epithelial monolayers by genistein but not by CPX or MPB‐07British Journal of Pharmacology, 137
A. Bachmann, U. Russ, S. Waldegger, U. Quast (2000)
Potent stimulation and inhibition of the CFTR Cl− current by phloxine BBritish Journal of Pharmacology, 131
M. Mense, P. Vergani, Dennis White, Gal Altberg, A. Nairn, D. Gadsby (2006)
In vivo phosphorylation of CFTR promotes formation of a nucleotide‐binding domain heterodimerThe EMBO Journal, 25
L. Al-Nakkash, Shenghui Hu, Min Li, T. Hwang (2001)
A common mechanism for cystic fibrosis transmembrane conductance regulator protein activation by genistein and benzimidazolone analogs.The Journal of pharmacology and experimental therapeutics, 296 2
Z. Cai, D. Sheppard (2002)
Phloxine B Interacts with the Cystic Fibrosis Transmembrane Conductance Regulator at Multiple Sites to Modulate Channel Activity* 210The Journal of Biological Chemistry, 277
C. Guay-Broder, Kenneth Jacobson, S. Barnoy, Z. Cabantchik, William Guggino, Pamela Zeitlin, R. Turner, Leoncio Vergara, O. Eidelman, Harvey Pollard (1995)
A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine selectively activates chloride efflux from human epithelial and mouse fibroblast cell lines expressing the cystic fibrosis transmembrane regulator delta F508 mutation.Biochemistry, 34 28
J. Zieleński (2000)
Genotype and Phenotype in Cystic FibrosisRespiration, 67
P. French, J. Bijman, A. Bot, W. Boomaars, Bob Scholte, H. Jonge (1997)
Genistein activates CFTR Cl- channels via a tyrosine kinase- and protein phosphatase-independent mechanism.The American journal of physiology, 273 2 Pt 1
Fei Wang, S. Zeltwanger, I. Yang, A. Nairn, T. Hwang (1998)
Actions of Genistein on Cystic Fibrosis Transmembrane Conductance Regulator Channel GatingThe Journal of General Physiology, 111
B Illek, H Fischer, TE Machen (1998)
Genetic disorders of membrane transport. II. Regulation of CFTR by small molecules including HCO 3 -Am J Physiol, 275
B. Illek, H. Fischer, T. Machen (1998)
II. Regulation of CFTR by small molecules including[Formula: see text].American journal of physiology. Gastrointestinal and liver physiology, 275 6
The human cystic fibrosis transmembrane conductance regulator (CFTR) is a member of the superfamily of adenosine triphosphate (ATP)-binding cassette (ABC) transporter ATPases. This protein forms a Cl- channel with a complex regulation; gene mutations cause cystic fibrosis disease. We investigated the interaction between the protein and the flavone UCCF-029 using the patch-clamp technique in the excised inside-out configuration in order to study the molecular mechanism of action for this potentiator on completely phosphorylated channel (25 U/ml protein kinase A) and a relatively low level of ATP (0.3 mm). Low concentrations of UCCF-029 (<50 nm) increase the open probability (p o), favoring the channel transition to an activated state, while high UCCF-029 (>50 nm) levels determine inhibition of the CFTR by a reduction of the total open time. Our data suggest that this drug can potentiate CFTR by binding to a specific site on the nucleotide binding domain, promoting dimer formation. The response of CFTR to variable concentrations of ATP is not modified by application of the potentiator UCCF-029 at either low, activatory, concentration or high, inhibitory, levels. Hence, we conclude that the potentiator may not interfere with binding of ATP but probably acts at an independent site in the protein, interacting directly with CFTR to modulate channel activity.
The Journal of Membrane Biology – Springer Journals
Published: Sep 18, 2007
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.